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Abstract We conducted a prospective, randomized con-
trolled trial of an internet-based safer-sex intervention to
reduce HIV transmission risk behaviors. HIV-infected men
who have sex with men (n = 179) were randomized to
receive a monthly internet survey alone or a monthly sur-
vey plus tailored risk reduction messages over 12 months.
The primary outcome was the cumulative sexually trans-
mitted infection (STI) incidence over 12 months. Second-
ary outcomes included self-reported unprotected sex with
an at risk partner and disclosure of HIV status to partners.
In a modified intent to treat analysis, there was no differ-
ence in 12-month STI incidence between the intervention
and control arms (30 vs. 25 %, respectively; p = 0.5).
Unprotected sex decreased and disclosure increased over
time in both study arms. These improvements suggest that
addition of the risk-reduction messages provided little
benefit beyond the self-monitoring of risky behavior via
regular self-report risk behavior assessments (as was done
in both study arms).
Keywords Internet  Men who have sex with men  HIV 
Risk behaviors  Intervention  Randomized controlled
trial  Sexually transmitted infection
Introduction
The annual incidence of new HIV infections in the United
States remains persistently high in men who have sex with
men (MSM), the risk group which accounts for the
majority of new HIV infections [1]. Use of new tech-
nologies (e.g., internet, mobile phone applications) among
MSM to seek sex partners has been linked with sexually
transmitted infections (STIs), more sexual partners and
unprotected anal intercourse [2, 3]. However, the Internet
can also be utilized by public health providers for health
behavior interventions [4]. Therefore, using the Internet to
deliver HIV prevention is an attractive avenue for pre-
vention program implementation as the highest risk popu-
lation already uses this medium [5, 6.] However, few HIV
prevention interventions, delivered through these tech-
nologies, have been adequately tested for efficacy [7, 8].
Internet-based interventions tend to have small, but
significant, effects on health behaviors [9] [5, 6]. Despite
the small effects (perhaps due to the less personable and
passive nature of the medium), the accessibility and ease of
diffusion of this approach applied over a large audience can
still lead to behavioral change that has a population level
impact. Larger effects are found among interventions with
a theoretical basis, such as social cognitive theory (SCT)
[10], the transtheoretical model (TTM) [11], and the theory
of reasoned action/planned behavior (TPB) [12]. A previ-
ous meta-analysis of theory-based HIV prevention inter-
ventions found the most common program elements to
include educational information, behavioral skills/attitudi-
nal persuasions, and behavioral skills training [13].
There are a growing number of effective HIV prevention
interventions that are delivered in clinical settings. For
example, clinic-based interventions have reduced unsafe
sex among persons living with HIV [7, 14–16]. However, it
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is unclear whether the safer sex messages communicated
via health care providers/educators in these studies would
have similar effects when communicated through a tech-
nology-based medium. Emerging prevention efforts tar-
geting new technologies, such as internet-based safer sex
interventions and outreach efforts to promote HIV/STI
testing have shown promise [2, 17–21]. In this randomized
controlled trial among HIV-infected MSM, we evaluated
the efficacy of a brief internet-based intervention, provided
monthly for 1 year, to reduce STIs and HIV transmission
behaviors. Messages in this internet-based intervention
were adapted from the clinic/provider-based Partnership
for Health intervention [14], which has shown efficacy in
reducing unsafe sex.
Methods
Study Setting
The study was conducted from November 2010 to July
2012 at three Southern California sites (University of
California San Diego, University of Southern California,
and Harbor-University of California Los Angeles) of the
California Collaborative Treatment Group (CCTG), a
multi-institutional, HIV clinical research network.
Eligibility Criteria
Eligible participants were HIV-infected MSM (age
[18 years) in care at any of the CCTG clinics with risk of
HIV transmission as determined by having one or more of
the following criteria: (1) self-reported unprotected anal
sex (either receptive or insertive) with any partner in the
past 3 months; (2) more than two partners in the past year;
(3) having an HIV-uninfected or unknown status partner in
the past 3 months; and/or (4) any STI in the past year.
Other eligibility criteria included English speaking, ade-
quate computer skills for the study and no uncontrolled
psychiatric condition. All study participants gave informed
consent, and study procedures were approved by the
institutional review boards at all sites. Participants were
recruited from patients engaged in ongoing clinical care in
primary care HIV services.
Study and Intervention Design
The study was a randomized, controlled study comparing
the efficacy of an internet-based intervention to reduce the
incidence of STIs and high-risk sexual behavior by HIV-
infected MSM. Participants were randomized 1:1 to receive
either a monthly brief, computer accessed, sexual behavior
survey alone for 12 months (control), or the same monthly
survey plus Internet-delivered tailored messages concern-
ing safer-sex, disclosure of HIV status to sex partners, and
the initiation of antiretroviral therapy (ART) (intervention).
Randomization was stratified based on site, having a
computer at home (yes/no), and ART use (yes/no) to ensure
balance between the groups across each of these.
An electronic data management system was created
using a fully validated, secure, web-enabled software (that
conformed to 21 CFR Part 11 requirements), that enable
data collection and intervention delivery. The implemen-
tation of the computer intervention enabled study partici-
pants to input and receive their personal information in a
confidential and user-friendly manner. As participants
completed the web-based intervention, the data gathered
was automatically integrated with their clinical and
research data. This design facilitated real-time quality and
compliance monitoring (e.g., to actively monitor study
retention) by study staff. Clinicians did not have access to
this information and were blind to group assignment.
Messages for those randomized to the intervention arm
were tailored based on the participants’ prior month reported
risk of transmission, which was classified as: (1) ‘Very
Low’—0 %; (2) ‘Low’—\0.1 %; (3) ‘High’—0.1–1.0 %;
and (4) ‘Very High’—[1.0 %. Risk of transmission was
calculated using the number (N) of unprotected receptive
anal (Nra), insertive anal (Nai), insertive vaginal sex acts
(Niv), oral sex acts (No), and needle sharing (Nn) multiplied
by a probability (P) estimates of per contact transmission rate
for each act (Pra = 0.65*0.0011, Pai = 5*0.0011,
Piv = 0.0011, Po = 0.1*0.0011, Pnd = 3*0.0011), multi-
plied for adjustment of recent STI (if Yes sti = 3.7 times
increased risk, if No sti = 1) and ART use (if Yes art = 0.1,
if No art = 1) [22–24]. Thus estimated HIV transmission
risk is the combined risk of not transmitting HIV subtracted
from one or:
1 ½ð1 art*sti*PraÞNra  ð1 art*sti*Pia)Nia  ð1
 art*sti*Po)No  ð1 art*sti*Piv)Niv  ð1
 art*Pnd)Nn
(Risk probability scores were implemented using R, an
open source scientific computing package.). Each group
received a unique web page that would give a risk appro-
priate message. For example, if they were ‘Very Low’ they
would be told they had a low chance of transmitting HIV in
past month and were supported in continued low risk
behavior, whereas those with ‘High’ were told they had
significant risk of transmitting in the past month. Based on
this stratification, there were different intensities of other
static internet pages that had specific themes: (1) condom
use; (2) disclosure to sex partners; (3) reduced use of drugs
and alcohol; (4) initiation of ART (for those not reporting
being on ART). The theoretical framework for the
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intervention approach and risk behavior messages was
based on SCT [10] and the TTM of Change [11]. Messages
used social influences and promoted positive movements in
behavior based on the participant’s current behavior/intent
(e.g. those not on ART were encouraged to consider ART
or take steps to start ART depending on whether they had
no intention to start ART or intended to start ART,
respectively). Messages were partially adapted from the
clinic-based Partnership for Health intervention [14] and
pre-tested through focus groups with HIV-infected MSM
who informed development and changes to the intervention
content and approach. Intervention text and flow is pro-
vided in a supplementary document (actual webpages were
in color with pictures).
Study Procedures and Measures
Data was collected by both confidential in-person interview
and computer assisted survey self-report for all enrolled
participants. In-person interviews were used to determine
basic demographics, medical history, history of STIs, ART
use, concomitant medications, medication adherence, psy-
chiatric history, and depressive symptoms using Center for
Epidemiological Studies Depression Scale (CES-D).
Plasma HIV RNA and CD4 counts were abstracted from
clinical records. STI screening assessments at baseline and
every 3 months over 12 months included syphilis (serum
RPR and if positive confirmatory treponemal test), as well
as nucleic acid amplification testing (NAAT) of urine and
swabs of pharynx and rectum for chlamydia and gonorrhea
using Hologic Aptima. (Study clinic visits occurred every
3 months and included both STI screening and the web-
based assessments and did not need to coincide with clinic
treatment visits.) Newly diagnosed STIs were communi-
cated to participants and referral was made to their provider
or a local sexually transmitted disease clinic. Treatment
was confirmed by completion of a medication record
review. All STIs were verified by an independent and
blinded adjudication committee.
The primary outcome was the composite incidence
variable of any new STI at any anatomic site (syphilis,
gonorrhea, chlamydia) during the 12 months study period.
Secondary outcomes were derived from the computer
assisted self-report surveys for: (1) any unprotected
anal/vaginal sex with an HIV negative/unknown status
partner during the past month, and (2) disclosure of status
to HIV negative/unknown status partners (defined at each
visit as disclosure to all partners). There were up to six
disclosure questions (one per partner type: regular male
partners, casual male partners, regular female partners,
casual female partners, regular transgender partners, casual
transgender partners) per assessment. Each question had
four options (non-disclosure, B50 % of the time,[50 % of
the time, all disclosure), although we a priori planned to
analyze this variable as all versus not all disclosed.
Descriptive summaries at each visit by study arm revealed
only a few subjects (\10 %) selected the middle two
options at each visit. Thus we retained this disclosure
coding plan. Those not sexually active in subsequent
months we treated as all safe and all disclosed.
Because so few participants were not on ART at base-
line (n = 22), we were unable to meaningfully compare
ART initiation between study arms during the study period.
Statistical Analysis
The study was powered to compare the incidence rates of
the primary endpoint between the two study arms using a
two-sample binomial test for proportions. Initially, to
achieve 80 % power to detect a reduction in STI incidence
rates from 25 to 10 %, with a two-sided alpha of 0.05, we
estimated a need for 200 participants. Enrollment was
halted at 181 participants because of slow recruitment.
However, the statistical power of the study was not
impacted because the STI incidence rate was higher than
originally anticipated.
Baseline characteristics were summarized and compared
between study arms using Fisher’s exact test for categorical
variables and Wilcoxon Rank-Sum test for continuous
variables. Primary analyses were performed on a modified
intent-to-treat (mITT) population, defined as randomized
participants who completed the baseline visit (n = 179)
[25]. (A total of 181 participants were randomized but two
did not complete their baseline visit.) A logistic regression
model was used to compare the difference in any new STI
during the study between the study arms, adjusting for the
baseline STI status, ART use and methamphetamine use at
baseline. Secondary outcomes (self-reported unprotected
anal/vaginal sex and disclosure) were assessed using a
generalized estimating equation (GEE) model with study
arm, visit (treated as a categorical variable), study arm-by-
visit interaction as the dependent variables. Additional pre-
specified analyses (as determined by the investigators when
the protocol was developed) were performed on a subset
that completed 75 % or more of monthly internet visits (as-
treated- 9/12 months; n = 107) and for those that contin-
ued on study through month 12 (regardless of many
internet visits they completed; study completers, n = 140).
In subsequent sensitivity analyses, we examined changes
over time in the secondary outcomes using mixed models
and pairwise testing. Because the pattern of results were
similar, we present only the GEE model results below. A
p value of\0.05 was considered statistically significant.
Statistical analyses were performed in R (http://cran.r-pro
ject.org), version 3.0.2.
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Results
Baseline Analysis
From 188 screened, a total of 181 MSM met the eligibility
criteria for inclusion in the study and were randomized to
intervention or control and 179 individuals completed the
baseline visit (included in mITT; Table 1). All 181 par-
ticipants were MSM with approximately one-third White
Non-Hispanic, one-third Black Non-Hispanic and one-third
Hispanic. The majority (78 %) of participants were daily
internet users. Most were on ART (84 %), and 65 % had
plasma HIV RNA levels below detection. Baseline data
and factors associated with participants having
detectable HIV RNA values have been previously pub-
lished [26].
Most baseline factors were balanced between arms.
Participants in the intervention arm were more likely to
have had incomplete disclosure of their HIV status to their
partners at baseline (67 % compared to 50 %, p = 0.02).
Among those on ART, participants in the intervention arm
had been on therapy for longer (p = 0.03). Both arms had
similar high levels of baseline STIs: 28 and 30 % in the
intervention and control arms, respectively (p = 0.74).
Methamphetamine use in the past month was similar in the
intervention (18 %) and control (19 %) arms (p = 0.85).
Since the intervention focused on reducing HIV transmis-
sion and changing behaviors in the context of making
participants aware of potential risk, we evaluated the par-
ticipants’ baseline perception of their risk for transmitting
HIV. Self-perception of risk was balanced between arms,
based on the response to the question ‘‘could you have
infected someone with HIV in the past month’’. Overall 11
(12 %) in the intervention arm and 9 (10 %) in the control
arm responded that they believed it was ‘‘somewhat likely’’
or ‘‘almost certain’’.
Study Follow-Up
There were seven individuals that chose not to participate
or did not return to the randomization visit. From the 181
MSM that were randomized, 179 completed baseline
Table 1 Baseline characteristics for the modified intention to treat population (randomized and completed baseline visit)
Intervention
(n = 90) N (%)
Control
(n = 89) N (%)
p
Mean Age 44.6 42.7 0.15
Race/ethnicity
White 32 (36) 27 (30) 0.36
Black 28 (31) 27 (30)
Hispanic 28 (31) 29 (32)
Other 2 (3) 7 (8)
English as primary language 77 (86) 77 (86) [0.99
Internet use
More than once a day 43 (48) 45 (51) 0.84
Daily 29 (32) 23 (26)
Weekly or less 18 (20) 21 (23)
Education more than high school 69 (77) 67 (75) 0.33
Income C$2000/montha 14 (22) 16 (24) 0.74
Mean CD4, cells/mm3 559 531 0.36
On ART 76 (84) 74 (83) 0.84
Mean months on ARTb 46.3 34.8 0.03
HIV RNA undetectable 60 (67) 56 (63) 0.64
AIDS diagnosis 24 (27) 21 (24) 0.73
STI 25 (28) 27 (30) 0.74
Unprotected anal/vaginal sex past month 51 (57) 44 (50) 0.37
Incomplete disclosure of status 60 (67) 44 (50) 0.02
Any illicit drug use 32 (36) 43 (48) 0.10
ART antiretroviral therapy, STI sexually transmitted infection
a Of those who responded to this question
b Of those on ART
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assessments (Fig. 1). There were 39 loss to follow ups
during study and 140 study completers who attended the
12 month study visit. There was no difference in the
number of study completers by arm of study, 67 in the
control and 73 in the intervention arm (p = 0.37), nor was
there difference in time to premature discontinuation. The
majority of loss to follow ups were due to participants not
returning for study visits. There were 107 participants that
completed 75 % or more (as-treated) of the internet-based
component of the study (i.e. C9/12 months consisting of
any combination of the four visits in clinic and eight visits
out of clinic). Of the as-treated, 58 were in control and 49
were in the intervention arm.
At the close of the internet-based intervention visit, each
subject was asked to choose one risk behavior that they
would like to focus on in the next month and asked if they
had achieved their goals from the previous month. Affir-
mative responses to these target/goal questions ranged
from 71 to 86 % across the study visits.
Primary Endpoint
In the mITT analysis, the occurrence of any incident STI
during the study (Table 2) was 27 % overall, with no dif-
ference between the intervention and control arm (30 vs.
25 %, respectively; p = 0.50). Of the 27 participants with
any STI in the intervention arm, six subjects had two STIs
and two had three STIs while seven participants in the
control arm had two STIs. The number of visits with
incident STIs showed no difference between the arms
(p = 0.57). The multivariable logistic regression also
showed no difference comparing intervention to control
(OR = 1.35, 95 % CI 0.68–2.70, p = 0.38), adjusted for
STI status, ART and meth use at baseline. Subset analyses
did not show lower rates of STIs in the intervention arm.
The occurrence of any incident STI was 33 versus 28 %
(p = 0.59) among study completers and 24 versus 24 %
among the as-treated groups.
To evaluate if the lack of difference between arms in
STIs could potentially be explained by serosorting, we
evaluated the number of HIV-infected partners over the
course of the study; there was no between arm difference.
Secondary Endpoints
In the mITT, self-reported unprotected anal/vaginal sex
declined over time in both arms (Fig. 2). In the intervention
arm, the decline in unprotected anal/vaginal sex from
baseline was significant in 10/12 study months. In the
control arm, the decline in unprotected anal/vaginal sex
was significant in only three of the follow up months
(months 9, 10, 12). The intervention arm had greater rel-
ative decline in unprotected anal/vaginal sex only at month
11 compared to the control arm. In sub-analyses of the
study completers, the trend was similar. The intervention
arm had greater relative decline in unprotected anal/vaginal
Fig. 1 consort diagram of study
participants. Study completers
are those who continued on
study through month 12
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sex than the control arm in months 4, 7 and 11. Among the
as-treated, the intervention arm had greater relative decline
in unprotected anal/vaginal sex than the control in months
1, 2, 4, 7 and 11.
Self-reported disclosure to all HIV unknown/negative
partners increased over time in both arms (Fig. 3). In the
intervention arm, disclosure increased in all study months
compared to baseline (all p’s\ 0.05). The increase in
disclosure from baseline was greater in the intervention
arm (vs. control) at months 4, 5, and 6. Results were similar
among study completers and the as-treated. In sub-analyses
of the study completers, disclosure increased in all follow
up months compared to baseline and was higher than the
control arm in months 4, 6 and 7. Among the as-treated,
the intervention arm had higher rates of disclosure in ele-
ven of the follow up months compared to baseline and was
higher than the control in months 6 and 7.
Discussion
This randomized, controlled trial enrolled a cohort of
sexually active MSM living with HIV to receive a brief,
monthly risk assessment survey alone or in combination
with a web-based risk reduction intervention aimed to
reduce risky behavior. While there was no difference
between study arms in the primary endpoint of STI rates
over the course of the study, participants in the study in
Table 2 New sexual
transmitted infections (STI) on
study
Intervention
(n = 90)
Control
(n = 89)
p
Any incident STI after baseline (%) 27 (30) 22 (25) 0.50
Visits with new STI per subject
1 19 (21) 15 (17) 0.57
2 6 (7) 7 (8)
3 2 (2) 0 (0)
Fig. 2 Self report of any
unprotected anal/vaginal sex in
past month
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either arm reduced self-reported unprotected anal/vaginal
sex behavior and increased disclosure of HIV status to at
risk (unknown/negative) partners.
The primary endpoint of incident STIs was selected as
an objective, biological marker of high-risk sexual behav-
ior. Prevalent STIs were common at baseline (29 %),
reflecting the high risk characteristics of our study popu-
lation and confirming the need for risk reduction inter-
ventions. Over the course the study, in contrast with the
improvement in the self-reported secondary endpoints,
incident STIs were frequent with a cumulative incidence of
27 %. Precedent for discordance in STI rates, such as
syphilis, without concomitant rise in HIV rates has been
seen in epidemiological data [27]. In this study, the dis-
cordance between changes in unprotected sex and lack of
reduction in STIs did not appear to be explained by
increased serosorting, the number of partners, or strategic
positioning (i.e., receptive vs. insertive sex). However, the
absolute number of sexual acts (i.e. protected and unpro-
tected anal/vaginal sex acts) with HIV-infected partners
was not assessed. Thus, changes in serosorting risk
behaviors could not be entirely excluded. Likewise,
because the majority of participants were on ART, their
perceived risk of HIV transmission may have been dis-
cordant with STI acquisition, the primary endpoint of this
study. That is, a lower perceived risk of HIV transmission
(attributed to ART use) could drive an increased/continued
risk of STI transmission. Although this is a potential lim-
itation of using STIs as primary endpoint in current HIV
intervention efforts, it remains relevant as an indicator of
condomless sex and greater potential for HIV exposure,
including the potential for higher levels of the virus in the
fluids/tissues of STI infected persons [28, 29].
In HIV-infected individuals, having unprotected anal
sex with HIV unknown or uninfected partners is the highest
risk behavior for possible onward transmission events [22,
30]. Reduction in these events through fewer sexual
encounters or consistent use of condoms represents a
cornerstone in the combination prevention strategy in
addition to ARV therapy [31]. Although our intervention
delivered messages to minimize unprotected sexual
encounters with serodiscordant partners, we observed
reductions in unprotected sex in both study arms at follow
up visits compared to baseline assessments. Unprotected
sex in the intervention arm was lower than in the control
arm at several follow up months during the study. Further,
Fig. 3 Self report of disclosure
of status to sex partners in past
month
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participants with high adherence to the study protocol had
even fewer unprotected anal/vaginal sex acts and the rates
were significantly lower than in the control group at five
time points. It may be possible that these differences were
random fluctuations that are not meaningful. However, this
reduction in unprotected acts supports a potential dose
effect of study participation, either receiving the interven-
tion or simply having repeated assessment of risk behavior.
Consistent disclosure of HIV status can also reduce HIV
transmissions from HIV-infected MSM [32]. Disclosure
facilitates serosorting behaviors that are commonly prac-
ticed, but seroadpative practices are associated with
increased risk of transmission compared to avoiding all
unprotected sex [33]. Our intervention provided some
possible strategies to enable disclosure and the risk survey
questions (given to all participants) queried about disclo-
sure to regular and casual sexual partners. Compared to
baseline, disclosure of status was higher within participants
in the intervention arm and, in some months, the inter-
vention arm was significantly higher than the control arm
for both unprotected anal/vaginal sex and disclosure
outcomes.
Limitations of the present study were identified that
could be helpful in development of future on-line or mobile
interventions. The study intervention was built on html
platform that would not adjust to fit on a tablet or smart-
phone screen, both of which became more common in use
during the course of this study. Because digital approaches
have shown promise in pilot studies to reduce HIV trans-
mission risk behaviors, [34–36] future work should include
more dynamic content. The survey and intervention were
static and largely non personal (with few decision trees).
Future interventions can be enhanced by (i) rotating con-
tent; (ii) use of an avatar to deliver messages; (iii) devel-
opment of a more user-friendly experiences; and (iv)
adaption to a mobile device platform. Further, although
many study visits were integrated with clinic visits, clini-
cians did not have access to the reporting of their patients
who were study participants. More fully integrated visits,
with consented transparent risk monitoring by the patient
and clinician may increase the efficacy of this intervention
approach. For example, although the intervention group
was able to select behavioral goals for their next visit,
clinicians were unaware of these goals. For outcomes, the
self-reported measures for sexual risk behavior are subject
to bias that even when done on a computer could suffer
over the course of study from a tendency to report a more
desirable result. Because the secondary outcomes improved
in both groups, there may have been reporting bias or
alternatively some effect from participation and/or self-
reflection on reported risk behaviors. To address these
issues, more sensitive assessment tools need to be used.
One way to do this may be more frequent data capture such
as daily electronic diaries or text reporting where there may
be less bias.
Since participants in both study arms reduced their risk
behaviors, technology-based, brief, self-administered risk
assessments in general may influence transmission risk
behaviors in HIV-infected MSM. These findings are con-
sistent with prior research documenting positive behavior
change and risk sensitization following behavioral assess-
ment [37–39]. It may be that behavioral assessments alone
(versus none) could be sufficient or superior in promoting
behavior change compared to health education and mes-
sages alone [20.] Behavioral self-assessment is well suited
for large-scale delivery through new technologies; such
low intensity interventions could contribute significantly to
combination prevention strategies. Thus, future risk
reduction interventions should focus on the broader
implementation of regular risk-behavior monitoring and
utilization of newer mobile technologies that can be more
dynamic and pervasive. This may require a change in
approach to how clinical trials are done with new tech-
nologies that allow for larger scale of implementation that
can measure smaller effect sizes with sufficient power.
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